Accuracy and patient experience of the novel flash glucose monitoring system in children and young people with type 1 diabetes mellitus

Turner, Lucy; Alsaffar, Hussain; Simmons, Anna; Bradley, Anna Barton; Millar, Kathryn; Bradshaw, Noala; Thornborough, Keith; Mimnagh, Jonathan; Kerr, Sue; Mehta, Fulya; Paul, Princy; Ghatak, Atrayee; Senniappan, Senthil

doi:10.1530/endoabs.45.oc7.4

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The same was noted in our study, as MARD in this cohort of patients was higher than the MARD when FSL was studied in patients with type 1 diabetes mellitus. It was reported to be 10.9% in a small cohort of patients [ 15 ] and 13.9% in multicentre study that involved 89 participants with diabetes mellitus (4-17 years old) [ 16 ].…”

Section: Discussionmentioning

confidence: 99%

Continuous Flash Glucose Monitoring in children with Congenital Hyperinsulinism; first report on accuracy and patient experience

Alsaffar

Turner

Yung

et al. 2018

Int J Pediatr Endocrinol

Self Cite

View full text Add to dashboard Cite

BackgroundThe factory calibrated FreeStyle Libre (FSL) flash glucose monitoring system has been recently introduced for use in patients with diabetes mellitus. There are no reports available regarding its use in patients with congenital hyperinsulinism (CHI). We have assessed the accuracy of FSL compared to the finger prick capillary blood glucose (CBG) over 2 weeks period in patients with CHI and evaluated the parents’ experience of using FSL.MethodsFour hundred sixty-seven episodes of CBG along with corresponding swipe FSL readings were available from 11 children with CHI (0.5–5 years). A detailed questionnaire was completed by the parents.ResultsThe mean variation between the two methods was 0.29 mmol/l (SD ±1.07), higher readings by FSL compared to CBG. The FSL sensors stayed in-situ for an average period of 11.5 days. There was a positive correlation between the two methods (r = 0.7). The FSL tended to overestimate compared to CBG (bias = 0.29 mmol/l; 95% CI: 0.19 to 0.38). Only 70% of values were within the reference standard (±0.83 mmol/l) at glucose concentrations less than 5.6 mmol/l. The overall Mean Absolute Relative Difference (MARD) was 17.9%. Forty two episodes of hypoglycaemia (CBG < 3.5 mmol/l) were noted but FSL identified only 52% of these episodes. The Bland Altman analysis showed the 95% limits of agreement between the two methods ranging from − 1.8 (95% CI: -1.97 to − 1.64) to 2.37 (95% CI: 2.21 to 2.54). Majority of the parents found the glucose trend on FSL to be useful to detect and prevent hypoglycaemic episodes. All parents felt that FSL is a very easy and convenient method to measure the glucose especially during sleep. A significant proportion of parents felt that FSL readings were not accurate and 56% of parents expressed interest to continue using FSL after the trial period.ConclusionNoticeable variability between the two methods of measuring the glucose was noted. Despite the ease of using the FSL system, concerns related to accuracy, especially at low glucose values do remain although parents find the glucose trend to be very useful. Further larger trials are needed in CHI patients before FSL is recommended as a routine alternative method for measuring glucose levels.

show abstract

Section: Discussionmentioning

confidence: 99%